Enpicom is a company founded in 2018 headquartered in the Netherlands. Brouky records 4 investors associated with the company.
Enpicom develops cloud-based bioinformatics software for analysis and interpretation of next-generation sequencing (NGS) data, enabling laboratories and researchers to perform genomic analyses and support pathogen surveillance and molecular diagnostics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.